Physician

Roman Ivan Czubatyj, M.D.

According to 2025 Medicare claims, Roman Czubatyj, M.D. (NPI: 1972797892) practices rheumatology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is JOHN E. TOWER DO PC (NPI: 1417151036; TIN: 383265423) and primary practice location at 48307-6118. Czubatyj is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Czubatyj's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 332 traditional Medicare patients, billed 69,365 HCPCS/CPT codes, and received $2,463,045 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 696 prescription claims across 250 beneficiaries totaling $335,233 in drug costs, led by Methotrexate (Methotrexate Sodium). Open Payments data shows 339 records totaling $184,063. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $61,267 to $2,463,045. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $35,334 and ending at $335,233. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.5M2015 Medicare payment: $61,267 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $82,628 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $145,257 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $303,708 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $541,610 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $849,571 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,006,446 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $769,494 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,369,248 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,463,045 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015249727$61,267
20163251,210$82,628
20173132,851$145,257
20183097,554$303,708
201934515,538$541,610
202029432,756$849,571
202129735,162$1,006,446
202234844,893$769,494
202330345,656$1,369,248
202433269,365$2,463,045

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$509K$1.0M2015 Drug cost: $35,334 (USD; Tot_Drug_Cst)2016 Drug cost: $268,226 (USD; Tot_Drug_Cst)2017 Drug cost: $585,242 (USD; Tot_Drug_Cst)2018 Drug cost: $646,890 (USD; Tot_Drug_Cst)2019 Drug cost: $868,808 (USD; Tot_Drug_Cst)2020 Drug cost: $965,593 (USD; Tot_Drug_Cst)2021 Drug cost: $828,487 (USD; Tot_Drug_Cst)2022 Drug cost: $1,017,864 (USD; Tot_Drug_Cst)2023 Drug cost: $454,982 (USD; Tot_Drug_Cst)2024 Drug cost: $335,233 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015182746$35,334
20162671,311$268,226
20173251,939$585,242
20183301,790$646,890
20193712,034$868,808
20203132,020$965,593
20212961,661$828,487
20223401,754$1,017,864
2023248762$454,982
2024250696$335,233

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more8080$152
96413Administration of chemotherapy into vein, 1 hour or less73434$96
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more232324$96
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's186247$12
J1602Injection, golimumab, 1 mg, for intravenous use3928,750$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MethotrexateMethotrexate Sodium15610,152$7,039
Hydroxychloroquine SulfateHydroxychloroquine Sulfate554,590$3,819
LeflunomideLeflunomide623,264$3,281
SulfasalazineSulfasalazine362,394$1,252
PrednisonePrednisone1414,076$815

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.339$184,063Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Roman Ivan Czubatyj, M.D.?

Tedicare shows public-source Medicare data for Roman Ivan Czubatyj, M.D. (NPI 1972797892), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Roman Ivan Czubatyj, M.D. have ACO affiliation data?

Roman Ivan Czubatyj, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Roman Ivan Czubatyj, M.D.?

Roman Ivan Czubatyj, M.D. is linked to JOHN E. TOWER DO PC (billing NPI 1417151036) in the available physician profile data.

Does Roman Ivan Czubatyj, M.D. have Open Payments data?

Roman Ivan Czubatyj, M.D. has 339 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.